Clinical Trials Browser

Phase 2 × Gestational Trophoblastic Disease × dostarlimab × Clear all

NCT05405192 2023-02-28

Dostarlimab in Chemoresistant Gestational Trophoblastic Neoplasia

Phase 2 Withdrawn

Gestational Trophoblastic Disease